FR2934698B1 - Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede. - Google Patents

Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede.

Info

Publication number
FR2934698B1
FR2934698B1 FR0804414A FR0804414A FR2934698B1 FR 2934698 B1 FR2934698 B1 FR 2934698B1 FR 0804414 A FR0804414 A FR 0804414A FR 0804414 A FR0804414 A FR 0804414A FR 2934698 B1 FR2934698 B1 FR 2934698B1
Authority
FR
France
Prior art keywords
disease
prognosis
diagnosis
prostate cancer
linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0804414A
Other languages
English (en)
Other versions
FR2934698A1 (fr
Inventor
Karine Auribault
Jean Denis Muller
Tassin Geraldine Cancel
Olivier Cussenot
Stephane Gazut
Nicolas Gilardi
David Mercier
Jean Philippe Poli
Emmanuel Ramasso
Frederic Suard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CT DE RECH POUR LES PATHOLOGIES PROSTATIQUES CEREPP
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
CT DE RECH POUR LES PATHOLOGIES PROSTATIQUES CEREPP
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CT DE RECH POUR LES PATHOLOGIES PROSTATIQUES CEREPP, Commissariat a lEnergie Atomique CEA filed Critical CT DE RECH POUR LES PATHOLOGIES PROSTATIQUES CEREPP
Priority to FR0804414A priority Critical patent/FR2934698B1/fr
Priority to CA2733385A priority patent/CA2733385A1/fr
Priority to CN2009801386590A priority patent/CN102171698A/zh
Priority to EP09781338A priority patent/EP2318971A1/fr
Priority to PCT/EP2009/059930 priority patent/WO2010012823A1/fr
Priority to US13/056,746 priority patent/US20110301863A1/en
Publication of FR2934698A1 publication Critical patent/FR2934698A1/fr
Application granted granted Critical
Publication of FR2934698B1 publication Critical patent/FR2934698B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Organic Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Software Systems (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Evolutionary Computation (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0804414A 2008-08-01 2008-08-01 Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede. Expired - Fee Related FR2934698B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0804414A FR2934698B1 (fr) 2008-08-01 2008-08-01 Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede.
CA2733385A CA2733385A1 (fr) 2008-08-01 2009-07-31 Procede de prediction pour le depistage, le pronostic, le diagnostic ou la reponse therapeutique du cancer de la prostate et dispositif permettant la mise en oeuvre du procede
CN2009801386590A CN102171698A (zh) 2008-08-01 2009-07-31 前列腺癌的筛查、预后、诊断或治疗反应的预测方法和实施所述方法的装置
EP09781338A EP2318971A1 (fr) 2008-08-01 2009-07-31 Procede de prediction pour le depistage, le pronostic, le diagnostic ou la reponse therapeutique du cancer de la prostate et dispositif permettant la mise en oeuvre du procede
PCT/EP2009/059930 WO2010012823A1 (fr) 2008-08-01 2009-07-31 Procede de prediction pour le depistage, le pronostic, le diagnostic ou la reponse therapeutique du cancer de la prostate et dispositif permettant la mise en oeuvre du procede
US13/056,746 US20110301863A1 (en) 2008-08-01 2009-07-31 Prediction method for the screening, prognosis, diagnosis or therapeutic response of prostate cancer, and device for implementing said method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804414A FR2934698B1 (fr) 2008-08-01 2008-08-01 Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede.

Publications (2)

Publication Number Publication Date
FR2934698A1 FR2934698A1 (fr) 2010-02-05
FR2934698B1 true FR2934698B1 (fr) 2011-11-18

Family

ID=40394423

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0804414A Expired - Fee Related FR2934698B1 (fr) 2008-08-01 2008-08-01 Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede.

Country Status (6)

Country Link
US (1) US20110301863A1 (fr)
EP (1) EP2318971A1 (fr)
CN (1) CN102171698A (fr)
CA (1) CA2733385A1 (fr)
FR (1) FR2934698B1 (fr)
WO (1) WO2010012823A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9732389B2 (en) 2010-09-03 2017-08-15 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
US8924325B1 (en) * 2011-02-08 2014-12-30 Lockheed Martin Corporation Computerized target hostility determination and countermeasure
CN108108590A (zh) 2012-03-05 2018-06-01 阿克蒂克合伙公司 分析系统和方法
US9939533B2 (en) 2012-05-30 2018-04-10 Lucerno Dynamics, Llc System and method for the detection of gamma radiation from a radioactive analyte
US9002438B2 (en) 2012-05-30 2015-04-07 Lucerno Dynamics System for the detection of gamma radiation from a radioactive analyte
CN102994495A (zh) * 2012-11-02 2013-03-27 上海长海医院 一种与前列腺癌易感性相关的单核苷酸多态性位点及其应用
CN102899322A (zh) * 2012-11-02 2013-01-30 复旦大学 一种与前列腺癌易感性相关的单核苷酸多态性位点及其应用
DK2922967T3 (en) * 2012-11-20 2018-04-16 Phadia Ab PROCEDURE FOR VIEWING A PRESENCE OR NON-PRESENCE OF AGGRESSIVE PROSTATANCES
EP2759605B1 (fr) * 2013-01-25 2018-11-14 Signature Diagnostics AG Procédé permettant de prédire une manifestation de mesure d'un résultat d'un patient atteint d'un cancer
US20160378935A1 (en) * 2013-07-15 2016-12-29 Koninklijke Philips N.V. Imaging based response classification of a tissue of interest to a therapy treatment
AU2015230017B2 (en) 2014-03-11 2021-06-17 A3P Biomedical Ab Method for detecting a solid tumor cancer
US12326453B2 (en) 2014-03-28 2025-06-10 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
MX392384B (es) 2014-03-28 2025-03-24 Opko Diagnostics Llc Composiciones y metodos relacionados con el diagnostico de cancer de prostata.
JP6312253B2 (ja) * 2014-11-25 2018-04-18 学校法人 岩手医科大学 形質予測モデル作成方法および形質予測方法
EP3253800B1 (fr) 2015-03-27 2021-03-03 Opko Diagnostics, LLC Standards d'antigènes prostatiques et utilisations
KR20170061222A (ko) * 2015-11-25 2017-06-05 한국전자통신연구원 건강데이터 패턴의 일반화를 통한 건강수치 예측 방법 및 그 장치
US11416622B2 (en) * 2018-08-20 2022-08-16 Veracode, Inc. Open source vulnerability prediction with machine learning ensemble
US12357250B2 (en) 2019-04-02 2025-07-15 Lucerno Dynamics, Llc System and method of using temporal measurements of localized radiation to estimate the magnitude, location, and volume of radioactive material in the body
CN110604550B (zh) * 2019-09-24 2022-06-21 广州医科大学附属肿瘤医院 一种肿瘤放疗后正常组织器官并发症预测模型的建立方法
CN111582370B (zh) * 2020-05-08 2023-04-07 重庆工贸职业技术学院 一种基于粗糙集优化的脑转移瘤预后指标约简及分类方法
US20250313897A1 (en) * 2022-04-27 2025-10-09 Genetic Technologies Limited Methods of assessing risk of developing prostate cancer
CN119274816B (zh) * 2024-09-24 2025-12-26 合肥工业大学 一种针对传染病患者的特征模糊模型构建方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092888A1 (en) * 2003-09-23 2007-04-26 Cornelius Diamond Diagnostic markers of hypertension and methods of use thereof
US7908091B2 (en) * 2006-03-17 2011-03-15 Prometheus Laboratories Inc. Methods of predicting and monitoring tyrosine kinase inhibitor therapy
US7899625B2 (en) * 2006-07-27 2011-03-01 International Business Machines Corporation Method and system for robust classification strategy for cancer detection from mass spectrometry data
JP2010522537A (ja) * 2006-11-30 2010-07-08 ナビジェニクス インコーポレイティド 遺伝子分析系および方法

Also Published As

Publication number Publication date
US20110301863A1 (en) 2011-12-08
CA2733385A1 (fr) 2010-02-04
FR2934698A1 (fr) 2010-02-05
WO2010012823A1 (fr) 2010-02-04
CN102171698A (zh) 2011-08-31
EP2318971A1 (fr) 2011-05-11

Similar Documents

Publication Publication Date Title
Rizzetto et al. Impact of sequencing depth and read length on single cell RNA sequencing data of T cells
Liao et al. Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis
EP1724698A3 (fr) Système et procédé de prédiction de l'effet du traitement, et programme informatique correspondant
Sadkovsky et al. PPPM (Predictive, Preventive and Personalized Medicine) as a new model of the national and international healthcare services and thus a promising strategy to prevent a disease: from basics to practice
Pross et al. Quality and resource efficiency in hospital service provision: A geoadditive stochastic frontier analysis of stroke quality of care in Germany
Fenny et al. Trends and causes of socioeconomic inequalities in maternal healthcare in Ghana, 2003–2014
Yang et al. Global trends and stratified analysis of aortic aneurysm mortality: insights from the GBD 2021 study
Ma et al. Deep5hmC: predicting genome-wide 5-hydroxymethylcytosine landscape via a multimodal deep learning model
Fagery et al. Integrating multi-cancer early detection (MCED) tests with standard cancer screening: system dynamics model development and feasibility testing
Živanović et al. System biology Modeling for drug optimization
Nian et al. Causal associations between immune cell phenotypes and varicose veins: A mendelian randomization analysis
Thummarakoti Leveraging Cloud Computing and Cutting-Edge Technology for Early Cancer Diagnosis
Szigeti et al. Neuronal actin cytoskeleton gain of function in the human brain
Fang et al. A nomogram based on CT radiomics and clinical risk factors for prediction of prognosis of hypertensive intracerebral hemorrhage
Teng et al. Improving multi-trait genomic prediction by incorporating local genetic correlations
Salomi et al. Need, application and characteristics of big data analytics in healthcare—A survey
Seminati et al. Economic assessment of NGS testing workflow for NSCLC in a healthcare setting
Schade et al. A data-and model-driven approach for cancer treatment
Böcking Comparability of tumor-cytogenetics and-DNA-cytometry
Artufel et al. Molecular protocol for HER2/neu analysis in breast carcinoma
Martelletti et al. The Future of Headache Disorders through AI Tools
Shahraki et al. Smart Acute Stroke Quality Registry Design-Data Elements Identification.
Suppan et al. Clinical Use of Liquid Biopsy in Metastatic Breast Cancer—An ESSO‐EYSAC International Survey
Kong et al. A strategy for the automatic diagnostic pipeline towards feature-based models: a primer with pleural invasion prediction from preoperative PET/CT images
LANGLOIS et al. Strengthening health policy and systems: the role of evidence synthesis

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20180430